Welcome to GeorgiaLifeScience.com
GeorgiaLifeScience.com is part of a specialized network of state- and province-based biotechnology, medical device,
and life science sites that includes more than 4,500 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise their job openings, events, facility availability and other services at the state level,
regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting
services.
 More...
Destination Georgia
Are you considering a move to Georgia? Relocating your business to
Georgia? Starting a company? Or just interested in Georgia?
This section will answer many of your questions regarding the life science industry in Georgia, the province's
economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history,
industry resources, and more.
More...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- Corn farmers who use Monsanto advanced technology eligible for lower insurance premiums Farmers in 11 states who plant a majority of their corn acres using hybrid seeds featuring YieldGard Plus with Roundup Ready Corn 2, YieldGard VT Triple and YieldGard VT Triple PRO technology from Monsanto Company will have an opportunity to lower their crop insurance premiums in 2009.
Monsanto Company August 19, 2008
- Patient side point-of-care testing enables quicker treatment decisions Patient side point-of-care testing - where diagnostic testing is conducted at or near the site of the patient - enables doctors to make decisions on patients presenting with chest pain up to 20 minutes faster than those whose lab tests are evaluated by a standard lab.
Abbott August 19, 2008
- BMS and PDL BioPharma enter alliance to develop novel treatment for multiple myeloma Bristol-Myers Squibb Company and PDL BioPharma announced an agreement for the global development and commercialization of PDL BioPharma's anti-CS1 antibody, elotuzumab, previously known as HuLuc63, currently in Phase I development for multiple myeloma.
Bristol-Myers Squibb Company August 19, 2008
- Salix Pharmaceuticals announces proposed convertible note offering Salix Pharmaceuticals announced its intention to offer, subject to market and other customary conditions, $50 million aggregate principal amount of convertible senior notes due 2028 to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
Salix Pharmaceuticals, Ltd. August 18, 2008
- Salix Pharmaceuticals prices convertible notes offering Salix Pharmaceuticals announced the pricing of its offering of $55 million aggregate principal amount of 5.5% convertible senior notes due 2028 to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
Salix Pharmaceuticals Ltd. August 18, 2008
More... | Submit News Release | National News
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Georgia's BioHistory
Why is there a biotechnology industry in Georgia? Will the industry continue
to grow in Georgia? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Georgia BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Georgia.
More...
BioEvolution Posters
More...
Pre-teens Need Vaccines Too!
Vaccines are not just for infants. As kids get older, protection provided by
some childhood vaccines can begin to wear off. Kids can also develop risks for
more diseases as they enter their pre-teen years. Help your child transition
into adolescence in a healthy way by staying up-to-date on pre-teen
vaccines.
Doctors recommend that all 11 and 12 year olds get the Tdap and
meningococcal vaccines; 11- and 12-year-old girls should also get the human
papillomavirus (HPV) vaccine.
More...
BioFact
(1883) - Francis Galton's Enquiries into Human Faculty introduces the term eugenics and suggests that humans can be improved by selective breeding.
It's a Small World
|
| |
Bacteria Culture
| |
Science Quote
"This world, after all our science and sciences, is still a miracle; wonderful, inscrutable, magical and more, to whosoever will think of it."
| - |
Thomas Carlyle, Scottish historian
|
|
(1795-1881)
|
|
